No Prescription |
 |
 | ||
|
XYLOCAINE Pump Spray Generic Lidocaine |
|
| ||
No Prescription » Prescription Drugs 17 » XYLOCAINE Pump Spray Generic Lidocaine Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:This medicine contains the active ingredient lidocaine hydrochloride (previously known as lignocaine hydrochloride in the UK) which is a type of medicine called a local anaesthetic. It works by temporarily blocking the pathway of pain signals along nerves. Pain is caused by the stimulation of pain receptors at the ends of nerves. The stimulation causes sodium to enter the nerve ending which causes an electrical signal to build up in the nerve. When this electrical signal is big enough it passes along the nerve to the brain where the signal is interpreted as pain. Lidocaine works by stopping the sodium entering the nerve ending at the site of the pain. This prevents an electrical signal building up and passing along the nerve fibres to the brain. In this way lidocaine causes numbness and relieves pain at the area it is applied to. Buy XYLOCAINE Pump Spray Generic Lidocaine and other Prescription Drugs 17 products online at Medstore. 5018
About XYLOCAINE Pump Spray Generic Lidocaine: Product Type: Prescription Drugs 17 XYLOCAINE Pump Spray ( Generic Lidocaine ) XYLOCAINE Pump Spray (Generic Lidocaine) Generic Lidocaine 10% 50mL Generic Lidocaine XYLOCAINE Pump Spray
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
